Meet our speakers
Director of Regulatory Affairs, Americas, Chiltern International Founder and Director, Centre for Motor Interaction, C4Pain Nuala Brennan, Vice President Clinical Trials, PanGenetics BV Senior Director, Group head - Research Clinical Pharmacology, Pfizer Global R&D Translational Sciences / Preclinical Safety, Novartis Institutes for BioMedical Research Modelling & Simulation Expert, Schering-Plough Research Institute Director of Toxicology, Takeda Global R&D Executive Director, Innovative Medicines Initiative CBE, Professor of Pharmacology, Oxford University Associate Vice President, Experimental Medicine & Bioanalysis, Ferring Pharmaceuticals Technical Lead Statistician, AstraZeneca Dr Orest Hurko, Assistant Vice President, Discovery Translational Research, Pfizer Inc Senior Vice President, Early Development Services, PRA International Senior Preclinical Assessor, Pre-authorisation, Coordinator Early Phase Development, Federal Agency for Medicines and Health Products Principal Scientific Officer, MHRA Senior Director Safety Assessment, AstraZeneca Dr Chetan Lathia, Director Global Clincal Pharmacology, Bayer Corp Principal Clinical Investigator, Medical Affairs and Clinical Development, GlaxoSmithKline EOOD Vice President Neuroscience & Ophthalmology Research & Development, Franchise Integrator, Merck Ltd Director, Safety and Risk Management, Pfizer Inc Chief Medical Officer and Vice President Cardiology, Medifacts International Inc Clinical Research Advisor, AEPODIA Research Fellow, Director, Clinical Statistics, Global Stats & Data Mgmt, Abbott Laboratories Director Drug Safety Risk Management, Roche - Genentech Dr Gareth Shackleton, Assistant Research Director, Global Metabolism and Pharmacokinetics, Sanofi-Aventis Academic Research Fellow, Pfizer Inc Senior Research Fellow, Quotient Clinical Jolanda van de Logt, Research Physician Phase IIa, Kendle Netherlands Senior Vice President, Head Global Early Development, Bayer Schering Pharma AG
|
|
|
|
|
©Terrapinn Holdings Ltd. MMX
